PaulStephenAisenMD

Physician

Dr. Aisen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 West Arbor Dr Mc 0949
Ucsd Medical Center
San Diego, CA 92103
Phone+1 858-622-2028

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1979 - 1982
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979, MD

PubMed

The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence.
Paul Aisen, Randall J Bateman, Damian Crowther, Jeff Cummings, John Dwyer
Alzheimer's & Dementia. 2025-01-01
Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials.
Gustavo A Jimenez-Maggiora, Michael C Donohue, Michael S Rafii, Rema Raman, Paul S Aisen
The Journal of Prevention of Alzheimer's Disease. 2025-01-01
1 citations
Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
Dustin B Hammers, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone, Laurel Beckett
Alzheimer's & Dementia. 2025-01-01

Alzheimer's Drug from Eisai and Biogen Slows Cognitive Decline, Side-Effects in FocusNovember 30th, 2022
New Alzheimer’s Drug Slows Cognitive DeclineNovember 30th, 2022
Alzheimer’s Drug Slows Cognitive Decline,November 30th, 2022
Join now to see all